GASTRIC CANCER JHH 2002 - 2006. Johns Hopkins Hospital Gastric Cancer 2002-2006, All Cases n=317 Analytic - Initially Diagnosed and/or received all or.

Slides:

Advertisements

Similar presentations

“Taking Care of Tomorrows Patient Better than Today”… the Future is Now Set A1 – Title Slide David O’Malley, M.D.

Advertisements

COLON CANCER: CURRENT SURGICAL MANAGEMENT OPTIONS. ANTHONY D.I. SIBIYA, MD., GABORONE PRIVATE HOSPITAL.

Canadian Cancer Risk Management Model: A new health policy tool useful in policy decisions related to lung cancer WK Evans, M Wolfson, WM Flanagan, J Oderkirk,

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

Impact of Cancer Diagnosis and Chemotherapy on Mammography Use Xinhua Yu, M.B., Ph.D. A. Marshall McBean, M.D., M.Sc. Beth A. Virnig, Ph.D., M.P.H Division.

Dr. LP Si Tseung Kwan O Hospital. Introduction CA stomach is the 4 th most commonly diagnosed malignancy worldwide 2 nd most common cause of cancer-related.

Prognostic factors for breast cancer survival in affluent and deprived areas Jasmina Stefoski-Mikeljevic.

FEMALE BREAST CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/03/20014.

These slides were released by the speaker for internal use by Novartis.

Casefinding & Follow-Up Dolores E. McCord, RHIT, CTR Piedmont Hospital Atlanta, Georgia.

Lung Cancer Emily Cauchon Katie Reeves Emily Cauchon Katie Reeves.

10 Minutes Talk 吳華席 Hua-Hsi Wu, MD OB/GYN, VGH-TPE Sep 08, 2008.

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/02/2013.

PROSTATE CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/01/2013.

MELANOMA JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

2014 Cancer Program Performance Outcomes. Introduction Saint Agnes Medical Center has proudly maintained a American College of Surgeons’ Commission on.

A Glimpse of the Science Behind the American Cancer Society Access to Care Campaign Impact of Being Uninsured or Underinsured on Individuals with Cancer.

LUNG CANCER Johns Hopkins Hospital Lung Cancer, Non-Small Cell , All Cases n=1364 Analytic - Initially Diagnosed and/or received all.

PANCREATIC CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY 2009.

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

Acknowledgements This report differs from the submitted abstract due to further subdivision of patients into analytic and non- analytic, and focus on the.

2013 C ANCER P ROGRAM A NNUAL R EPORT C OLORECTAL CANCER Praneetha Narahari, MD Ellen Malek, CTR Saint Agnes Medical Center Cancer Registry 1303.

Adjuvant Radiation is Not Associated with Improved Survival in Patients with Positive Margins Following Lobectomy for Stage I & II Non-Small Cell Lung.

Differential Diagnoses September 25, You are a psychologist who has been referred 5 cases from the local school district. You have been asked to.

1 Sarcoma Ages >= ** Analytic - Initially Diagnosed and/or received all or part of 1st course treatment at.

Breast cancer affects 1 in 8 women during their lives. 1 Population Statistics.

ANALYTIC LUNG CANCER by CLASS N = 351 Class 0: Dx’d at JHH only 1: Dx’d at JHH and received all/part of 1st course tx at JHH 2: Dx’d at an outside facility.

SNDA Letrozole (Femara®) Indication: First-line therapy in post- menopausal women with advanced breast cancer. Prior approval: Second-line therapy.

Cancer Committee Meeting May 11, 2015 Cancer Liaison Physician Report Karen Lisa Smith MD MPH.

NCDB Report on Breast Cancer at Sibley Cancer Committee Feb Cancer Liaison Physician Karen Lisa Smith MD MPH.

HEAD/NECK CARCINOMA Johns Hopkins Hospital.

Radical vs Partial Nephrectomy for treatment of renal cell carcinoma at Prince Hussein Urology Centre Dr. Mohammad Alserhan Urology specialist Prince Hussein.

Journal Club Dr. Eyad Al-Saeed Radiation Oncology 12 January, 2008.

Quality & Sustainability in Cancer Control: A System Performance Spotlight Report To use a hyperlink, right click on it and select ‘Open Hyperlink’, or.

Linking Electronic Health Records Across Institutions to Understand Why Women Seek Care at Multiple Sites for Breast Cancer Caroline A. Thompson, PhD,

Association of Family History with Cancer Recurrence and Survival in Patients with Gastric Cancer Journal of Clinical Oncology : R2 Hwang.

Presented at the NAACCR Annual Conference Quebec City June 22, 2010.

Johns Hopkins Hospital Cancer Registry Melanoma

JHH Prostate Cancer Prostate Cancer Cases Diagnosed 1999 – 2004 Analytic vs. Non-Analytic n=7776 * Analytic - Initially Diagnosed and/or received.

The Role of the HCC Cancer Registry in Facilitating Cancer Research Linda Cope, CTR HCC Registry Coordinator

ESMO 2016 Nivolumab Data Study Ph Indication Line N Arms 1o EP ORR mDR

Palliative Care in MND Barry Laird Clinician Scientist in Palliative Medicine, University of Edinburgh and PRC Consultant in Palliative Medicine, St Columba’s.

Short-term outcome of neo-adjuvant chemotherapy

Supplemental Figure 1: FOXM1 mRNA level analysis in 48 ovarian tissues

Fig. 1 Frequency distribution of initial palliative treatment modalities used. EBRT, external beam radiotherapy. Initial palliative treatment modality.

NON-SMALL CELL LUNG CANCER

JOHNS HOPKINS HOSPITAL CANCER REGISTRY

Presented By Deborah Schrag at 2016 ASCO Annual Meeting

Johns Hopkins Hospital Malignant and Benign Brain/CNS

JOHNS HOPKINS CANCER REGISTRY 2009

ANALYTIC PANCREATIC CANCER by CLASS N = 369

Johns Hopkins Hospital Cancer Registry

Staging system for gastric carcinoma

OPTIMIZING TREATMENT FOR ADVANCED OVARIAN CANCER:

People living with AIDS in Maine at the end of 1984

تهیه کننده: استاد مربوطه: بهار 1392

Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival Elizabeth A. David, MD, Robert J. Canter,

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study Stephen H. Culp, Paul.

Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A

4155 primary hepatocellular carcinoma with known diagnosis month/year

Hypothesis Testing: Two-Sample Inference

Superior sulcus (Pancoast) tumor: experience with 105 patients

Thymoma: A Population-Based Study of the Management and Outcomes for the Province of British Columbia Caroline Mariano, MD, Diana N. Ionescu, MD, Winson.

Solving Equations 3x+7 –7 13 –7 =.

• Kaplan-Meier analyses of (A) overall survival (OS) of the whole cohort (n=173), (B) OS from time of diagnosis of high-risk melanoma among those who remained.

Data Analytics course.

Kaplan-Meier (K-M) curves of progression-free survival (PFS) of the entire cohort of patients with metastatic gastric cancer treated with RAD001. Kaplan-Meier.

Kaplan-Meier (K-M) curves of progression-free survival (PFS) in 54 patients with metastatic gastric cancer treated with RAD001. Kaplan-Meier (K-M) curves.

Presentation transcript:

GASTRIC CANCER JHH

Johns Hopkins Hospital Gastric Cancer , All Cases n=317 Analytic - Initially Diagnosed and/or received all or part of 1st course treatment at JHH **Non-Analytic - Initially diagnosed & treated elsewhere to JHH for treatment of recurrent, metastatic or progression of disease.

Johns Hopkins Hospital Gastric Cancer, , All Cases Age at Diagnosis n= /

Johns Hopkins Hospital Gastric Cancer, , All Cases by Race n=

Johns Hopkins Hospital Gastric Cancer, , All Cases Maryland by County n=210

Johns Hopkins Hospital Gastric Cancer, , All Cases by State n=317

Johns Hopkins Hospital Gastric Cancer, All Cases n=317

Johns Hopkins Hospital Gastric Cancer, , Analytic Class 1 & 2 by AJCC Stage n = 289 1/ There are 4 Class

Johns Hopkins Hospital Gastric Cancer, , Analytic Class 1&2 by Treatment, AJCC Stage I-IV n=282** *63% of pt who had no treatment were AJCC IV. Referred to Hospice. 2 stage III refused. **Unknown stage not included

Johns Hopkins Hospital Gastric Cancer, JHH Class 1 & 2 AJCC I - IV n = 282 AJCC Stage I II IIIIV Surgery Only66%35%25%17% Surgery/Chemo 3% 5% 12%15% Chemotherapy Only 2% 0% 8%25% Surgery, Rad & Chemo14% 50%42% 6% Other 8%10% 6%15% No Treatment 7% 0% 7%22% TOTAL 100% 100% 100% 100% No comparative NCDB Data

Johns Hopkins Hospital Gastric Cancer, , Analytic Class 1&2. Relative Five Year Survival n = 379* *No comparative NCDB data